In sub-Saharan Africa and Elsewhere, We Need to Look Harder for TB
The scope and intensity of the global TB epidemic is fueled by antiquated and inadequate TB drugs, most of which were developed more than 50 years ago.
PREMIUM Blogs
Dr. Morounfolu Olugbosi
By NewVision Reporter
Journalists @NewVision
BLOGS | HEALTH | TB
Before COVID-19 came along, tuberculosis (TB) was a primary focus of health authorities in sub-Saharan Africa. In 2019, approximately 1.4 million people were diagnosed with